Induction of Membrane Ceramides: A Novel Strategy to Interfere with T Lymphocyte Cytoskeletal Reorganisation in Viral Immunosuppression by Gassert, Evelyn et al.
Induction of Membrane Ceramides: A Novel Strategy to
Interfere with T Lymphocyte Cytoskeletal Reorganisation
in Viral Immunosuppression
Evelyn Gassert
1., Elita Avota
1., Harry Harms
1, Georg Krohne
2, Erich Gulbins
3, Sibylle
Schneider-Schaulies
1*
1Institute for Virology and Immunobiology, University of Wu ¨rzburg, Wu ¨rzburg, Germany, 2Department of Electron Microscopy, University of Wu ¨rzburg, Wu ¨rzburg,
Germany, 3Department for Molecular Biology, University of Essen, Essen, Germany
Abstract
Silencing of T cell activation and function is a highly efficient strategy of immunosuppression induced by pathogens. By
promoting formation of membrane microdomains essential for clustering of receptors and signalling platforms in the
plasma membrane, ceramides accumulating as a result of membrane sphingomyelin breakdown are not only essential for
assembly of signalling complexes and pathogen entry, but also act as signalling modulators, e. g. by regulating relay of
phosphatidyl-inositol-3-kinase (PI3K) signalling. Their role in T lymphocyte functions has not been addressed as yet. We now
show that measles virus (MV), which interacts with the surface of T cells and thereby efficiently interferes with stimulated
dynamic reorganisation of their actin cytoskeleton, causes ceramide accumulation in human T cells in a neutral (NSM) and
acid (ASM) sphingomyelinase–dependent manner. Ceramides induced by MV, but also bacterial sphingomyelinase,
efficiently interfered with formation of membrane protrusions and T cell spreading and front/rear polarisation in response to
b1 integrin ligation or aCD3/CD28 activation, and this was rescued upon pharmacological or genetic ablation of ASM/NSM
activity. Moreover, membrane ceramide accumulation downmodulated chemokine-induced T cell motility on fibronectin.
Altogether, these findings highlight an as yet unrecognised concept of pathogens able to cause membrane ceramide
accumulation to target essential processes in T cell activation and function by preventing stimulated actin cytoskeletal
dynamics.
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Introduction
Activation of sphingomyelinases (SMases) which differ in their
respective pH optimum and activity largely accounts for
accumulation of membrane ceramides; that of the acid sphingo-
myelinase (ASM) was related to the transformation of small
membrane cholesterol and sphingomyelin (SM) enriched micro-
domains (also referred to as rafts) into large, ceramide-enriched
membrane platforms in response to a variety of external stimuli
[1,2]. In hematopoetic cells, these include ligation of death
receptors [3,4], CD40, FccRII and CD28 [5]. Certain pathogens
such as P. aeruginosa, S. aureus and rhinovirus also promote and rely
on formation of ceramide-enriched platforms for entry (reviewed
in [6,7]), while these interfere with fusion-dependent uptake of
HIV [8–10]. Regulation of lateral diffusion and recruitment of
surface receptors and membrane-proximal signalling complexes
are general mechanisms of ceramide-enriched platforms to
enhance initiation of or modulate signalling pathways [2,11–13],
including integrin-signalling in endothelial and neural cells
[14,15], and cytoskeletal remodeling in breast cancer MCF-7 cells
independently of apoptotic ceramide signalling [16,17].
For migratory cells such as T cells, dynamic reorganisation of
the actin cytoskeleton in response to external soluble and cell-
associated stimuli are required for polarisation, motility, scanning
of the APC surface, and lastly, formation of immunological
synapses (IS) [18–20]. Regulated sorting and clustering of
receptors to cellular subdomains such as the leading edge or
uropod during migration, or the IS and the distal pole,
respectively, relies on a dynamic coupling of surface receptors to
the actin cytoskeleton by linker proteins including ezrin/radixin/
moesin (ERM) family proteins or talin. Morphologically, retrac-
tion of actin-based protrusions facilitates the formation of
interaction platforms and exposure of surface molecules from
crypts [18]. Given the importance of these processes, their
deregulations by viruses expectedly would be of great relevance
to immunomodulation, in particular, immunosuppression.
Measles virus (MV) was the first pathogen recognised as
immunosuppressive. Its ability to prevent entry of stimulated T
lymphocytes into the G1 phase of the cell cycle in vitro, is reflected
by the general impairment of T lymphocytes isolated from patients
to expand in response to mitogenic activation [21,22]. Since
within this population only a minor fraction of T cells is actually
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infection and rather predominantly result from signalling by the
viral glycoprotein complex expressed on the surface of infected
dendritic cells (DCs) [22,24]. Surface bound MV colocalised with
GM1 on primary T cells, indicating that MV signalling is initiated
within detergent resistent membrane microdomains, and this
occurs independently of CD150, the MV uptake receptor [25].
MV surface signalling ablates activation of the phosphatidyl-
inositol-3-(PI3)/Akt kinase pathway in vitro and in vivo [26–28] and
consequently, T cell activation, adherence, polarisation and
lamellopodia formation in response to TCR ligation or integrin
signalling as well as receptor clustering in conjugates formed with
mature DCs are impaired [29]. In the absence of external
activation, MV signalling to primary human T cells was found to
cause inhibition of Akt kinase activation, dephosphorylation of
ERM proteins, activation of RhoA and collapse of actin-based
microvilli [29] all of which are consistent with activation of SMases
and/or membrane ceramide accumulation in non-hematopoetic
cells [16,17,30–33].
We now show that MV signalling causes activation of both
NSM and ASM and ceramide accumulation on human T cells.
Ablation of ASM or NSM protein expression or function did not
rescue MV induced-induced inhibition of T cell proliferation yet
effectively abolished interference with actin cytoskeletal dynamics.
In line with these observations, T cell exposure to MV or bacterial
SMase (bSMase) also modulated T cell motility, altogether
suggesting a novel function for membrane ceramide in regulating
T cell polarisation and motility, and thereby T cell dynamics.
Results
MV causes ASM and NSM activation and accumulation of
membrane ceramides on T cells
To analyse the ability of MV to promote ceramide accumula-
tion on the surface of T cells, Jurkat cells were exposed to MV or a
MOCK preparation in the presence of a fusion inhibitory peptide.
Subsequently, levels of cell surface ceramide were determined in
an assay based on immunodetection of a ceramide-specific
antibody bound to intact cells (spot assay) [34]. MV, but not
MOCK or the fusion inhibitory peptide alone stimulated an
approximately three-fold increase of extrafacial ceramide raising
after 5 min and peaking at 15 min (normalised to basal expression
levels determined for untreated cells) (Fig. 1A). In addition to this
assay, also FACS analyses confirmed surface accumulation of
ceramides on T cells in response to MV (Fig. 1B), but not to a
recombinant expressing VSV G protein instead of the MV
glycoproteins documenting their importance in surface ceramide
induction (Fig. 1C). The appearance of extrafacial ceramide
accumulations consistent with ceramide-enriched platforms was
also detected by immunocytochemistry (exemplified for a 10 min
MV exposure in Fig. 1D). To analyse whether MV induced
surface ceramides relied on ASM activation, we analysed cell
surface display of this enzyme by spot assay. Slightly preceding
ceramides, extrafacial ASM started accumulating within 5 min
after MV exposure, peaked at 10 min and subsequently declined
(Fig. 1E). A biochemical assay using
14C-labeled sphingomyelin as
a substrate, confirmed the kinetics of ASM activation by MV
(Fig. 1F). Interestingly, transient activation of NSM significantly
over background levels at 5 min post MV exposure was
reproducibly detected (Fig. 1F). Importantly, MV caused an
approximately threefold surface accumulation of ASM and
ceramides also in primary human T cells though with a slightly
slower kinetics than determined for Jurkat cells (Fig. 1G, and not
shown). Pre-exposure to the ASM inhibitor amitriptyline efficient-
ly prevented MV induced ceramide surface accumulation on
Jurkat and primary T cells (Fig. 1H, left panel, and not shown).
Interestingly, inhibition of NSM by a pharmacological (using
GW4689 at concentrations not toxic to the target cells, Fig. 1H,
left panel) or a genetic approach (using an NSM2-specific siRNA,
the efficiency of which is exemplified in Fig. 2C) also prevented
ceramide accumulation on primary or Jurkat T cells (Fig. 1H, right
panel, and not shown), indicating that NSM activation by MV is
essential for this phenomenon and may relate to that of ASM
subsequently. Taken together, MV contact promotes activation of
both ASM and NSM along with surface ceramide accumulation
within few minutes on human T cells.
Ceramide generation does not account for MV-induced
inhibition of stimulated T cell expansion
If generation of membrane ceramides were to account directly
for contact dependent MV inhibition of T cell proliferation, the
latter should be abolished on ablation of SMase function or
expression. As established, MV but not MOCK exposure
prevented a-CD3/CD28 driven expansion of human T cells,
and amitriptyline did not alter the effects of MV on T cell
proliferation (Fig. 2A). MV-induced T cell inhibition was also
insensitive to myriocin or fumonisin B1, indicating that this
process did not involve de novo sphingolipid biosynthesis. Murine T
cells also respond to MV signalling [26], and thus the impact of
ASM activation on stimulated T cell expansion was assessed by
analysing the sensitivity of a-CD3/CD28 driven proliferation of
spleen cells isolated from Asm knockout (AsmKO) mice. These
proved to be equally responsive to MV signalling as wild-type cells,
indicating that Asm activation is not sufficient to cause MV
proliferative arrest (Fig. 2B). Similarly, neither pharmacological
nor genetic interference with NSM rescued MV-induced inhibi-
tion of aCD3/CD28-stimulated proliferation of human T cells
(Fig. 2C). This was also true for cultures where both ASM and
NSM activity had been inhibited and MV, but not exposure to C16
ceramide or bSMase efficiently inhibited a-CD3/CD28 stimulated
T cell expansion as determined by a 16 hrs
3H-thymidine pulse
Author Summary
The ability of measles virus (MV) to impair T cell–
dependent immune responses noted more than 100 years
ago continues to be central to the severe generalised
immunosuppression by this virus. Much has been learned
about receptors and mechanisms, which determine the
predilection of MV for hematopoetic cells. In contrast, little
is known on a molecular level how MV interferes with
processes relaying extracellular signals to T cells which
translate into reorganisation of their cytoskeleton as
required for their migration and cell–cell communication.
Our study now shows that MV activates sphingomyelinas-
es and ceramide accumulation in T cell membranes and
this severely impairs integrity and stimulated reorganisa-
tion of their actin cytoskeleton, morphologically resulting
in collapse of actin based protrusions, and functionally in
impaired motility. During these studies, we appreciated,
however, that cues other than MV eliciting ceramide
accumulation in general also caused T cell paralysis. This
indicates that ceramide accumulation and its consequenc-
es are not only a novel concept for MV-induced T cell
silencing, but rather reflects a general strategy which may
apply to extracellular ligands including pathogens able to
promote plasma membrane ceramide accumulation,
thereby preventing T cell activation.
Ceramides Impair T Cell Cytoskeleton
PLoS Pathogens | www.plospathogens.org 2 October 2009 | Volume 5 | Issue 10 | e1000623Figure 1. MV causes SMase activation and membrane ceramide accumulation in human T cells. (A–D) Extracellular oriented ceramide
accumulation was detected on Jurkat T cells exposed to MV (black symbols) or a MOCK preparation (white symbols) after the time intervals indicated.
(A) By spot assay. Levels indicated were normalised to those measured on untreated cells; one out of three independent experiments is shown (inset:
MV: upper, MOCK bottom row). (B–D) By surface detection. (B,C) FACScan on cells exposed to (B) MOCK (solid black curve) or MV (filled histogram)
(exemplified for a 10 min exposure) (the grey line indicates staining of the isotype control antibody) or (C) MOCK, MGV (black triangles) or MV for the
time intervals indicated (min), (D) by immunofluorescent staining (exemplified for a 10 min exposure to MOCK (a and blow up in c) or MV (b and blow
up in d) (bars represent 25 (a, b) or 5 mm (c, d)). (E) Surface display of ASM was determined on Jurkat T cells exposed to MOCK (white symbols) or MV
(black symbols) for the time intervals indicated by spot assay (inset; MV upper, MOCK bottom row (as in (A), values were normalised to those
measured on untreated cells)). (F) ASM (open symbols) and NSM (closed symbols) activation by MV was measured by conversion of
14C-
sphingomyelin to
14C-phosphorylcholine by extracts prepared from MV or MOCK-treated cells within 1 hr. Values shown indicate production of
14C-
phosphorylcholine by MV over time, each expressed in relation to the respective MOCK control; levels of NSM activation significantly exceeding the
background (t-test, p=0.01) are indicated by an asterisk (data were generated in three independent experiments, standard deviations are indicated).
(G) ASM surface display on primary human T cells in response to MOCK (white symbols) or MV (black symbols) over time measured by spot assay
(inset; MV middle, MOCK bottom row). CD28-activation was used as a positive control (inset, upper row). (H) Left panel: Primary human T cells were
left untreated (grey curve) or pre-exposed to amitriptyline (filled histogram) or GW4869 (black curve) for 2 hrs prior to MV exposure for the time
intervals indicated, stained for ceramide surface display and analysed by FACScan. Right panel: Primary T cells were transfected using a scrambled
(filled histogram) or a NSM2-specific siRNA (black and white line) prior to exposure to MOCK (white line) or MV (filled histogram and black line).
doi:10.1371/journal.ppat.1000623.g001
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sufficient to cause MV T cell arrest.
Ceramide generation accounts for MV-induced paralysis
of microvillar membrane protrusions and T cell
polarisation
We reasoned that ceramides could relate to the collapse of actin
based microvillar structures on T cells exposed to MV associated
with low phosphorylation levels of the ERM family cytoskeletal
linker proteins ezrin and moesin [29]. Both features resembled
findings reported for MCF-7 breast cancer cells, where cisplatin-
induced ASM activation accounted for loss of lamellopodia/
filopodia and p-ezrin [17]. In line with our previous observations,
a substantial fraction of MV exposed human T cells remained
small and rounded on fibronectin (FN) with condensed cortical
actin instead of spreading or aquiring a front-rear polarity with
enrichment of CD43 in the uropod ([29], and Fig. 3A). Strikingly,
pre-exposure to amitriptyline, but also to GW4869 as well as
siRNA-mediated NSM knock-down efficiently rescued the
morphotrophic effects of MV on these cells (Fig. 3A) indicating
that ceramides generated due to SMase activation essentially
account for the loss of T cell polarisation. As revealed by scanning
electron microscopy (SEM) analyses, microvillar structures
projected from the majority of control T cells about 40% of
which revealed a clearly polarised morphology, while in cultures
exposed to MV, the majority of cells was devoid of organised
surface projections and the fraction of polarised cells was
substantially lower (Fig. 3B). In line with our confocal microscop-
ical findings, amitriptyline pre-treated T cells exposed to MV
polarised as efficiently as the controls and retained organised
microvillar structures. Amitriptyline did not affect the morphology
of partially and non-polarised cells present in either culture at
roughly the same frequency (Fig. 3B). To prove the importance of
SMase activation in this process directly, the morphology of spleen
cells isolated from AsmKO mice on FN was analysed by SEM.
Though membrane protrusions in murine spleen cells were overall
shorter than those seen on human T cells, MV exposure caused a
detectable loss of these structures in spleen cells of wild-tpye
animals (Fig. 3C, left panel, first and second row). In contrast,
AmsKO spleen cells, some of which spontaneously formed
extended ruffles on FN (Fig. 3C, left panel, middle row), were
refractory to MV-induced cytoskeletal collapse (Fig. 3C, fourth
row and quantified in C, right upper panel), however, were highly
susceptible to that induced upon exogenous membrane ceramide
accumulation by exposure to C16-ceramide or bSMase (Fig. 3C,
right bottom panel, and not shown). Altogether, these data
indicate that MV interference with cytoskeletal dynamics in T
cells, as reflected by the loss of membrane protrusions and
responsivenenss to b1 integrin stimulated polarisation, relies on
membrane ceramide generation.
To lend further proof to the hypothesis that membrane
ceramide accumulation per se impedes stimulated T cell
cytoskeletal dynamics, the impact of bSMase or addition of C16-
ceramide (or inactive dihydro-C16 (dC16)) on b1 integrin
stimulated T cell polarisation was analysed. When used at
concentrations not interfering with T cell viability, bSMase and
C16, yet not dC16 exposed T cells inefficiently spreaded and
polarised on FN as revealed by a low frequency of cells acquiring
the typical hand-mirror morphology (Fig. 4A, left and middle
panel). Rather, actin-rich more central clusters with podosomal
morphology were observed in a substantial percentage of cells, and
this was particularly seen upon bSMase exposure (Fig. 4A, left
panel, arrow). Though less efficiently than in primary T cells, FN
seeding induced polarisation of cortical actin in a substantial
percentage of Jurkat T cells, and this was dose dependently
abrogated upon pre-exposure to bSMase or C16 (Fig. 4A, right
panel, and not shown).
Since we have previously shown that ezrin/moesin phosphor-
ylation is downmodulated in human T cells in response to MV
[29], we analysed phosphorylation levels of these proteins (the
ERM species expressed in human T cells [35]) in response to C16
and bSMase. Both compounds reduced p-ezrin levels, while p-
moesin was less affected (Fig. 4B).
Figure 2. MV-induced SMase activation does not account for MV interference with stimulated T cell expansion. (A) Human primary T
cells left untreated or treated with amitriptyline (ami), fumonisin B (Fum B1), myriocin (myr) for 2 hrs were exposed to MV or MOCK in the presence of
FIP and aCD3/CD28 stimulated. Proliferation was monitored by
3H-thymidine incorporation during the last 16 hrs of culture. One representative out
of three independent experiments (each performed in triplicates) using three different donors is shown. (B) Spleen cells isolated from AsmKO or wild-
type mice were exposed to MOCK or MV and aCD3/CD28 stimulated. Proliferation rates were determined as described in A, with those seen for the
MOCK controls set to 100%. (C) Human primary T cells were either left untreated, or transfected with a scrambled (control siRNA) or a NSM2-specific
siRNA (NSM2) or pretreated with the NSM-inhibitor (GW4869). 24 hrs after inhibitor treatment or 96 hrs after transfection, cells were exposed to MV
(black bars) or MOCK (white bar), aCD3/CD28-stimulated and proliferation rates were determined as described in (A). Values obtained (in three
independent experiments) for MOCK were each set to 100% and those obtained MV exposed samples (black bottom line) were determined as
relative to the individual MOCK controls. The efficiency of NSM2 silencing by control or the specific siRNA was controlled by RT-PCR and WB (inset).
doi:10.1371/journal.ppat.1000623.g002
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PLoS Pathogens | www.plospathogens.org 4 October 2009 | Volume 5 | Issue 10 | e1000623Figure 3. SMase activation accounts for MV-induced prevention of T cell polarisation and loss of membrane protrusions. (A) Human
T cells were transfected with a NSM2-specific or a scrambled siRNA for 96 hrs or exposed to amitriptyline (ami) or GW4869 2 hrs prior to MOCK (right
panel, white bars) or MV (right panel, black bars) exposure for 2 hrs at 4uC and subsequently seeded onto FN-coated slides. Cells were fixed after
30 min and stained for f-actin and CD43 (exemplified in the left panel, with the scale bar representing 5 mm) and the percentage of cells revealing a
front-rear polarisation with CD43 enriched in the uropod was determined. At least 100 cells per culture were recruited into the analysis. (B) Human T
cell cultures exposed to MOCK or MV (pre-exposed to amitriptyline for 24 hrs or not) were seeded onto FN coated slides and analysed by SEM (left
panel; bars represent 5 mm). Right panel: Cells in each culture were scored into morphological categories (non-, partially or fully polarized; see insets
for examples; 100 cells per culture were counted) and the respective percentage of cells exposed to MV (black bars) or MOCK (white bars) was
determined. (C) Left panel: Spleen cells from wild-type (upper and second row) or AsmKO mice (middle to bottom row) were exposed to MOCK
(upper and third row), MV (second and fourth row) or C16 ceramide (bottom row) prior to seeding onto FN and subsequent SEM analysis. Right, upper
panel: Wild-type or AsmKO spleen cells exposed to MV (black bars) or MOCK (white bars) were seeded onto FN and the percentages of cells forming
membrane protrusions in each culture were determined by SEM. Right, bottom panel: AsmKO cells exposed to MOCK (white bars) or C16 ceramide
(black bars) were seeded onto FN and percentages of cells revealing membrane protrusions or with smoot appearance were determined. Both right
panels: At least 100 cells were recruited into the analysis per culture. Levels of significance were determined using a t-test (p=0.01).
doi:10.1371/journal.ppat.1000623.g003
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PLoS Pathogens | www.plospathogens.org 5 October 2009 | Volume 5 | Issue 10 | e1000623Figure4. Ceramide generation abolishes T cell polarisation and spreading as well as pERM levels. Human T cells (left untreated or exposed
to bSMase, C16 or dC16 were seeded onto (A) FN (left andmiddle panel; right panel shows Jurkat cells 30 min after FN seeding) or (C) aCD3/CD28 coated
slides, and stained, in (A), for f-actin alone or in (C), together with pERM protein. F-actin aggregates consistent with formation of podosome-like
structures are exemplified by arrows. The percentages of cells acquiring a polarised phenotype in (A) (middle and right panel) or in (C), differing in
morphologybydevelopingorganisedroundorincompletelamellopodiaorrevealingpERMclustersandpodosome-likestructures(arrows)areindicated
(at least each 100 cells were counted per culture). Scale bars represent 5 mm. (B) Levels of p-ezrin/moesin were determined in primary human T cells left
untreatedorexposedtobSMase attheconcentrationsindicated(leftpanel) orexposedtodC16orC16(50 mm)(rightpanel),each for2 hrs byWB.p-ezrin
or p-moesin levels were quantified by densitometry (bottom graphs). Detection of moesin served as loading control.
doi:10.1371/journal.ppat.1000623.g004
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impairs the ability of T cells to organise actin cytoskeletal
structures to stimuli other than FN, primary T cells were exposed
to bSMase or C16 (or dC16) and seeded onto costimulatory slides
coated with a-CD3/CD28 antibodies (Fig. 4C). About 25% of
untreated or dC16 exposed cells efficiently spreaded to organise
extended lamellopodia with pERM proteins lining and thereby
tethering the plasma membrane to the underlying f-actin
cytoskeleton (Fig. 4C, exemplified in the upper row and graph).
In line with ceramides interfering with stimulated cytoskeletal
dynamics, lamellopodia formation (as determined by f-actin
detection) barely occurred in C16 or bSMase exposed cultures
(Fig. 4C, upper graph). In those, costimulation induced morpho-
logical alterations were largely atypical with incomplete and
asymmetrical lamellopodia (prevailing upon bSMase exposure)
(exemplified in Fig. 4C, middle row and graph), or a limited
spreading ability (mainly seen after C16 treatment) (Fig. 4C,
bottom row and graph). Though C16 and bSMase caused overall
loss of p-ezrin, p-moesin was much less affected (Fig. 4B). Thus,
not surprisingly, p-ERMs recognised by the polyclonal antibody
were readily detectable by immunofluorescence performed on T
cells exposed to these compounds. Interestingly, in bSMase or C16-
exposed cells, pERMs (including both ezrin and the more
abundant moesin proteins) apparently revealed an aberrant
subcellular distribution in response to TCR ligation. In bSMase
treated cells, both f-actin and a very high proportion of pERMs
localised to peripheral sites of the asymmetrical lamellopodia, yet
revealed little overlap (Fig. 4C, middle row). In contrast, C16
promoted appearance of actin- and pERM-rich clusters consistent
with attempted formation of podosomes which only partially
overlapped and revealed a somewhat random distribution both at
peripheral and internal sites (Fig. 4C, bottom panels). In summary,
our results are consistent with membrane ceramides interfering
with reorganisation of the actin cytoskeleton in response to both
FN or TCR ligation in primary T cells and this is associated with a
loss of predominantly p-ezrin, and this mirrors our observations
made after MV exposure of these cells [29].
MV-induced ceramide impairs T cell motility
MV-induced ceramide generation efficiently interferes with
stimulated actin cytoskeletal rearrangements as required for
polarisation, and this could also impact on T cell motility. We
thus analysed migration of T cells on FN in the presence of the
chemokine SDF-1. Both bSMase and MV exposure abolished
polarisation of T cells on FN (Fig. 3A and 4A), and thus, the SDF-
1 receptor CXCR4, accumulated at the leading edge of untreated
T cells (Fig. 5A, left panels), but not in bSMase or MV-treated
cultures (Fig. 5A, second and fourth panels). There, CXCR4
apparently was retained in cytosolic clusters, which were even
partially retained when cells were pretreated with amitriptyline
prior to MV exposure (Fig. 5A, third panels) though in these
cultures, a fraction of CXCR4 localised to the leading egde. When
seeded onto FN alone, T cells of all cultures analysed barely
migrated (not shown). Upon addition of SDF-1, T cells not
exposed to MV migrated efficiently and, as revealed by the tracks
recorded (exemplified in Fig. 5B) almost directionally, with 31 out
of 34 exceeding an arbitrary threshold velocity of 7 mm/min. In
contrast, a substantial fraction of cells remained below this velocity
in MV-exposed cultures and interestingly, apparently circled
rather than migrated (Fig. 5B). Indicating that these alterations
related to SMase activation, pre-treatment with amitriptyline at
least partially rescued T cell motility in this system (Fig. 5B), which
was also effectively blocked upon exposure of T cells to bSMase
(Fig. 5C). Altogether these data indicate that ceramide accumu-
lation, as exemplified for that induced by bSMase and a model
ligand, MV, efficiently ablates directed motility of T cells and
presumably thereby, T cell recruitment to sites of inflammation.
Discussion
Ceramides regulate the biophysical property of the plasma
membrane, but also transform small cholesterol/SM enriched
membrane microdomains enriched into platforms where receptors
are concentrated and scaffolds for assembly of membrane
proximal signalling complexes are provided [2,36–41]. Their role
in signalling initation and promotion has mainly been analysed
after death receptor ligation followed by apoptosis [2,36].
Importantly, ceramides interfere with activation of the PI3 kinase
and their downstream effectors [32,42,43]. In addition, ASM
activation has been linked to PP2A-dependent dephosphorylation
of ezrin, a member of the cytoskeletal linker ERM proteins and
thereby, loss of membrane protrusions in MCF-7 cells [17]. In
mobile cells such as T lymphocytes where cytoskeletal reorganisa-
tions are of direct functional importance the impact of SMase
activation is ill defined as yet.
T cell silencing induced by MV contact is characterised by PI3K
inhibition, RhoA activation, membrane transformation in raft-like
platforms, loss of membrane protrusions and ezrin phosphorylation
[22] all of which are compatible with ceramide generation, and
indeed, MV promoted ceramide generation and changes in cell
morphology and motility resembled those seen upon exposure of
cells to bSMase or C16-ceramide (Fig. 3, 4). Interestingly, MV
induced activation of both NSM (likely representing NSM2 [44])
and ASM (Fig. 1F). In our system, activation of ASM may even rely
on that of NSM, because pharmacological or genetic interference
with NSM efficiently prevented extrafacial ceramide accumulation
(predominantly resulting from ASM action on extrafacial SM and
therefore efficiently prevented by amitrityline) both an Jurkat and
primary human T cells (Fig. 1H, and not shown for Jurkat cells).
NSM2 localises or can be recruited to the inner leaflet of the plasma
membrane where it catalyses hydrolysis of sphingomyelin which is,
however, not very abundant there [44]. Similar to that by MV,
ASM activation andinduction ofsurface ceramidesby TNF-a relies
on initial activation of NSM [45], yet underlying mechanisms
remain unclear. Possibly, NSM-catalysed ceramide generation in
the inner leaflet triggers ASM surface display by its established
activity in promoting vesicle fusion [39,46], which may include that
of ASM containing membraneous compartments with the plasma
membrane.
The mode of how MV activates SMases remains unresolved at
present. It clearly does so by surface contact which is evident from
the experimental conditions (binding in the presence of FIP) and
the fast kinetic of SMase activation. As established, MV externally
interacts with GM1 binding domains in primary T cells [28], and
though CD150, the identified high affinity receptor required for
MV entry, can localise to rafts [47], it is unlikely to substantially
contribute to MV-induced SMase activation in T cells. This is
because the latter occurs in resting primary T cells where CD150
expression is low [48,49] and in Jurkat cells which do not express
this protein on their surface [50]. Since we focussed on
consequences of ceramide generation on T cell functions, their
role in MV entry into these cells types was not specifically
addressed. Unlike that of viruses entering by endocytosis such as
Sindbis virus, rhinovirus and adenovirus which induce and benefit
from local ceramide production [6,51–53], MV entry occurs by
pH-independent fusion at the plasma membrane. For HIV, which
also uses this mode of entry, ceramides were found inhibitory by
preventing the lateral diffusion of CD4. Rather, inceased levels of
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PLoS Pathogens | www.plospathogens.org 7 October 2009 | Volume 5 | Issue 10 | e1000623Figure 5. Ceramide accumulation abolishes redistribution of CXCR4 and affects T cell chemotactic motility. (A) T cells left untreated
(first column) or exposed to MV (second column) alone or after a 2 h pretreatment with amitriptilyne (third column) or to bSMase (fourth column)
were seeded onto FN and stained for f-actin and CXCR4. Size bars represent 5 mm. (B and C) T cells were left untreated (each: left panel) or pretreated
with amitriptyline ((B), right panel) or not before exposure to MV for 2 h at 4uC ((B), middle panel) or treated with bSMase ((C), middle and right
panels) for 2 hrs at 37uC and seeded onto FN with addition of SDF-1 (1,5 mg/ml). Migration of cells on FN in response to SDF-1 was recorded over a
time period of 10 min and the individual velocities of cells and their trajectories were calculated using ImageJ software. Tracks of cells faster than an
arbitrary velocity threshold of 7 mm/min in B, or 9 mm/min in C, are indicated in black, those slower in red in each panel. Examples shown are
representative of three individual experiments including different donors with a total of at least 120 cells recorded for each experimental setup.
doi:10.1371/journal.ppat.1000623.g005
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uptake into the endolysosomal/degradative pathway [8–10]. If this
also applies to MV remains to be determined.
MV interference with TCR- or IL-2R driven PI3/Akt kinase
activation was found essential to the induction of T cell growth
arrest [26,27]. Ceramides can target the relay of PI3K signalling
[33,43,54]. Unlike that by MV (Fig. 2), inhibition of CD4 T cell
activation and proliferation after cholera toxin B (CTB) binding to
and generating ceramides from rafts was strictly NSM–dependent
and did not involve ASM [55]. Reasons for this discrepancy are
unclear at present. Notably, NSM activation by cholera toxin only
peaked much later than that induced by (after 25 min, rather than
5 min) (Fig. 1F). Moreover, MV but not CTB caused ASM
activation, and thus, though not directly analysed, ceramide
accumulation measured in extracts of CTB exposed cells, may not
be predominantly displayed at the cell surface [55]. Further
suggesting that signalling pathways modulated by CTB ligation of
GM1 and MV, though both causing ceramide accumulation, may
substantially differ, CTB, but not MV exposure interfered with
stimulated expression of early T cell activation markers CD25 and
CD69 [26,55,56].
Our study now provides direct evidence that ceramide
generation induced in a ligand (MV) dependent or independent
manner profoundly affects regulated dynamics of the T cell
cytoskeleton thereby modulating the ability of T cells to interact
with substrates (including the ECM), retain organised protrusions
and to migrate in response to chemotactic cues (Fig. 3–5). In
human T cells, exogenous ceramides efficiently interfered with
particularly p-ezrin levels (Fig. 4B), which is in line with findings
obtained in MCF-7 cells where these were also lost after bSMase
or C16 exposure [17]. In MCF-7 cells, the only pERM species
detected by the antibody used is p-ezrin, and thus, reduced pERM
levels in response to ceramide increase detected in lysates
corresponded to those in immunofluorescence [17]. In T cells,
moesin is much more abundant than ezrin, and interestingly, levels
of p-moesin were much less affected by bSMase or C16 (Fig. 4B).
Ezrin and moesin are important in T cell activation as directly
documented after targeted disruption of both proteins [35].
Ablation of ezrin alone did not affect partitioning of talin, PKC-
h or p-ZAP-70 to the IS or CD43, p85 or ezrin binding protein 50
(EBP50) into the distal pole complex, and this was also observed
when moesin was additionally silenced by RNAi. However,
moesin was incompletely silenced and thus functionally compen-
sated in partitioning membrane proteins to their respective cellular
poles [35,57]. In view of these findings, it is highly interesting that
p-moesin, though largely retained and most likely representing the
major pERM species detected by IF even upon ceramide increase
in T cells (Fig. 4B and C) cannot functionally compensate for loss
of p-ezrin in assisting aCD3/CD28-stimulated spread or FN-
induced polarisation (Fig. 4A and C). Thus, aberrant sorting of
otherwise preferentially p-ezrin associated proteins by p-moesin
may occur as well or rather mark direct impacts of ceramides on
actin polymerisation and/or branching in T cells.
As another direct consequence of ceramide-dependent interfer-
ence with cytoskeletal dynamics, responsiveness to migrational
cues is impaired (Fig. 5). Underlying mechanisms are likely to
include the inability of MV or bSMase exposed cells to polarise on
FN and thus, to redistribute CXCR4 to a leading edge and to
enable directed migration (Fig. 5A). Though this was not directly
assessed in our system where SDF-1 was directly added to the
culture medium, the more circulating movement of ceramide-
enriched T cells may reflect the more general than polarised signal
perception by CXCR4 which per se is not known to be affected
upon MV exposure (Fig. 5B and C). The general interference of
ceramide generation with actin cyoskeletal rearrangement is,
however, likely to be directly responsible for the block in T cell
motility observed in our system which may even be more
pronounced when analysed in a 3D environment, where leukocyte
motility is almost entirely dependent on actin flow [58,59]. It will
be interesting to see as to whether in these systems, which are
currently adopted, the obviously less effective signalling by MV
may equal to that seen after bSMase exposure (Fig. 5B and C).
Though also not experimentally addressed as yet, ceramide
generation, particularly when induced at a focal basis could be
predicted to affect formation of cellular interfaces such as the IS
and thereby directly impact on the efficiency of T cell conjugation
and activation. In support of this notion, MV signalling shown to
induce ceramides on T cells (Fig. 1), has been found to contribute
to destabilisation of conjugates formed between infected DCs and
T cells [60]. To what extent ceramide generation on T cells
impacts on infection-dependent immunomodulation by pathogens
is largely unknown. Experimental infections performed in AsmKO
mice so far involved pathogens uptake of which is ASM
dependent, and thus have been evaluated on differences relating
to susceptibility to infection. Though Asm per se enhances Sindbis
virus uptake, it also accounts for SV induced cell apoptosis and, as
documented more recently, production of highly virulent particles,
thereby at least partially explaining the enhanced sensitivity to
CNS infection and virus production in AsmKO mice [51,52].
Nsm2/3KO mice have not yet been experimentally infected, and
in common with AsmKO mice not systematically analysed with
regard to the impact of SMases on development and function of T
cells which, according to our in vitro findings, could be a highly
interesting avenue to follow.
Materials and Methods
Ethics statement
Primary human cells were obtained from the Department of
Transfusion Medicine, University of Wu ¨rzburg, and analysed
anonymized. All experiments involving human material were
conducted according to the principles expressed in the Declaration
of Helsinki and ethically approved by the Ethical Committee of
the Medical Faculty of the University of Wu ¨rzburg.
Cells, virus and infection experiments
Primary human T cells were enriched from peripheral blood
obtained from healthy donors by Ficoll gradient centrifugation
followed on nylon wool columns and, as Jurkat cells, maintained in
RPMI1640/10% FCS. Spleen cells were isolated from Asm–/–
knockout mice (AsmKO) and their C57BL6 wild-type littermates.
MV wild-type strain WTF and the MV recombinant MGV (both
grown on human lymphoblastoid BJAB cells in RPMI1640/10%
FCS) were titrated on marmoset lymphoblastoid B95a cells (kept
in RPMI1640/10%FCS). For exposure experiments, MV grown
on BJAB cells was purified by sucrose gradient ultracentrifugation
as was the MOCK control from uninfected BJAB cells. T cells
were cocultured with MV or, when indicated MGV (at a
multiplicity of infection (m.o.i.) of 1 each) or a MOCK preparation
(used at a corresponding protein/volume concentration) in the
presence of a fusion inhibitory peptide Z-D-Phe-L-Phe-Gly-OH
(Bachem, Heidelberg, Germany; 200 mM in DMSO) to prevent
infection of T cells throughout the experiment for 2 hrs at 4uC.
Ceramide/SMase detection
For surface detection of ceramides and ASM we adopted an
assay previously described [34]. Briefly, cells (each 3610
6)
stimulated for the time intervals indicated (a-CD28 (clone
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Heidelberg, Germany), MOCK, MGV or MV) were fixed in 1%
formaldehyde and incubated with a-ceramide IgM (clone MID
15B4, Alexis) or polyclonal rabbit a-ASM IgG (H-181; Santa
Cruz) over night at 4uC and washed extensively in PBS.
Cell bound antibody was desorbed for 30 sec with ice cold
100 mM glycine-HCl, pH 3.0, and spotted onto nitrocellulose
following neutralisation with 100 mM Tris-HCl pH 8.0. Antibod-
ies were detected by goat-a-mouse IgM (Dianova, Hamburg,
Germany) or IgG respectively conjugated to peroxidase (New
England Biolabs, Frankfurt, Germany) detected using ECL and
quantified using AIDA software (Raytest). Alternatively, cell
surface ceramides were detected using FACsCALIBUR after
incubation with specific primary and Alexa-488-conjugated
secondary a-mouse IgM (MolecularProbes).
ASM activity was determined as previously described [61] using
T cell extracts, while membrane enriched fractions were used for
detection of NSM activity [62] with 0,01 mCi N-methyl-
14C-
sphingomyelin used as a substrate at 37uC for 1 hr at pH 5.0 for
ASM and pH 7.4 for NSM in the presence of Mg2+.
14C-
phosphocholine produced was extracted by chloroform:methanol
(2:1, vol/vol) and measured by liquid scintillation counting of the
upper phases. Values indicated represent means of at least three
independent experiments involving different donors.
siRNA tranfection, RT-PCR analysis and Western Blot
analysis
For silencing of NSM2, human T cells were nucleofected twice
with a two days interval according to the manufacturer’s protocol
(Amaxa) with siRNA targeting human SMPD3 (NSM2) specific
[63] or, for control, a scrambled siRNA (Eurogentec, Belgium).
Before cells were recruited into the respective experiments (after
96 hrs), aliquots were harvested for nucleic acid extraction
(Qiagen, RNAeasy Kit) and subsequent RT-PCR analyses.
Forward 59-GCCCTTATCTTTCCATGCTACTG-39 and re-
verse 59-ACAGAGGCTGTCCTCTTAATGCT-39 primers were
used for specific SMPD3 amplification. Alternatively, protein
extracts prepared from transfected cells were used for detection of
NSM2 by immunoblot analysis using a NSM-specific goat
polyclonal antibody (Clone C-13, Santa Cruz). p-ERM (Cell
Signalling, Frankfurt, Germany) or moesin (clone 38/87 produced
in our laboratory)-specific and secondary HRP-conjugated goat a-
rabbit (Cell Signalling, Frankfurt, Germany) or goat a-mouse
(Dianova, Hamburg, Germany) antibodies were used to detect the
corresponding proteins by WB analysis. Signals obtained after
ECL development were acquired and quantified using the AIDA
software program (Raytest, Straubenhardt, Germany).
Immunostaining and scanning electron microscopy
(SEM)
T cells (when indicated pre-exposed for 2 hrs to amitriptyline
(10 mM), GW4869 (1,3 mM), recombinant bacterial sphingomy-
elinase (12,5 mU/ml, all Sigma-Aldrich, Taufkirchen, Germany) or
50 mMC 16- (BIOMOL, Hamburg, Germany) or dh-C16-ceramide
(Avanti Polar Lipids, Otto Norwald GmbH, Germany)) were
transferred onto 8-chamber slides (LabTekII, Nunc, Wiesbaden,
Germany) precoated with a-mouse IgG (Dianova, Hamburg,
Germany) (2 hrs at 37uC) and subsequently activated by CD3-
(clone UCHT-1) and CD28-specific antibodies (clone CD28.2)
(each 1 mg/ml) (both Beckton-Dickinson Biosciences Pharmingen,
Heidelberg, Germany) for 10 min at 37uC. Alternatively, T cells
were transferred for 30 min to chamber slides coated with
fibronectin (FN) (20 mg/ml in PBS; Sigma, Mu ¨nchen, Germany).
For immunostaining, cells were fixed in paraformaldehyde (4% in
PBS) and stained for membrane ceramide (clone MID 15B4, Alexis)
or, after permeabilisation (0.1% Triton X-100) for CD43, CXCR4
(clone 12G5, both: Santa Cruz) or p-ERM (Cell Signalling,
Frankfurt, Germany); actin was detected using Alexa488 or 2594
conjugated phalloidin (all Molecular Probes, Karlsruhe, Germany).
Fluorochrome G (Southern Biotech, Eching, Germany) mounted
samples were analysed byconfocal laser scanning microscopy(Laser
Scan Microscope, LSM510 Meta, Software version 3.2, SP2;
Axiovert 200 M microscope, Objective: 636; aperture 1.4 plan
apochromat; when indicated, vertical z-stacks were acquired (20
optical planes, 0.5 mm distance) and 3D deconvolutions were
performed (by using Zeiss software). For SEM, cells were seeded
onto FN coated slides for 30 min at 37uC and fixed by addition of
6.25% glutaraldehyde in 50 mM phosphate buffer (pH 7.2) for
10 min at RT and subsequently at 4uC overnight. After a washing
step, samples were dehydrated stepwise in acetone, critical point
dried and sputtered with platin/paladium before SEM analysis
(Zeiss DSM 962).
Proliferation and migration assay
Proliferation of human T cells or murine spleen cells was
determined after pre-incubation with antibodies directed against
human or murine CD3/CD28 (each 1 mg/ml in PBS for 30 min
at 4uC) and subsequent activation by seeding onto plate bound a-
mouse IgG (coated onto 96 well plates at 10 mg/ml in 50 mM Tris
pH 9.0 at 4uC over night) for 72 hrs (including a final 18 hrs pulse
labeling with
3H thymidine (0,5 mCi/well)). When indicated, cells
were pretreated with fumonisin B2 (50 mM) or myriocin (50 nM)
(both Sigma-Aldrich, Germany) amitriptilyne, GW4869 or siRNA
transfection as detailed above).
For tracking experiments, 5610
4 T cells (pre-treated or not as
indicated) were resuspended in 0,5% BSA/PBS supplemented with
1,5 mg/ml SDF-1 and placed onto FN-coated slides (m-SlideVI;
Ibidi). Before use slides were coated with 20 mg/ml FN in PBS at
4uC overnight, washed three times with PBS and blocked for 1 h at
37uC with 2,5% BSA/PBS. Cell images were scanned with a Laser
Scanning system (LSM 510 Meta, Zeiss) based on an inverted
microscope (Axiovert 200 M, Zeiss) through an objective (406, oil,
NA=1,3 Plan-Neofluar) at 37uC. An Argon/2 (488 nm) laser was
used for differential interference contrast (DIC). Images were
acquired every 30 sec for 10 min, trajectories and mean velocity of
individual cells was determined using ImageJ software (NIH;
http://rsb.info.nih.gov/ij/).
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